FR2781153B1 - Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques - Google Patents
Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiquesInfo
- Publication number
- FR2781153B1 FR2781153B1 FR9809058A FR9809058A FR2781153B1 FR 2781153 B1 FR2781153 B1 FR 2781153B1 FR 9809058 A FR9809058 A FR 9809058A FR 9809058 A FR9809058 A FR 9809058A FR 2781153 B1 FR2781153 B1 FR 2781153B1
- Authority
- FR
- France
- Prior art keywords
- flavonoid
- tumors
- treatment
- therapeutic composition
- cytotoxic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 229940127089 cytotoxic agent Drugs 0.000 title 1
- 239000002254 cytotoxic agent Substances 0.000 title 1
- 231100000599 cytotoxic agent Toxicity 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9809058A FR2781153B1 (fr) | 1998-07-15 | 1998-07-15 | Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
JP2000559841A JP2002520356A (ja) | 1998-07-15 | 1999-07-13 | 細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物 |
IL14058899A IL140588A0 (en) | 1998-07-15 | 1999-07-13 | Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents |
KR1020017000478A KR20020003349A (ko) | 1998-07-15 | 1999-07-13 | 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물 |
AU47890/99A AU4789099A (en) | 1998-07-15 | 1999-07-13 | Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
PCT/FR1999/001714 WO2000003706A1 (fr) | 1998-07-15 | 1999-07-13 | Composition therapeutique a base de flavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
EP99931342A EP1096930A1 (fr) | 1998-07-15 | 1999-07-13 | Composition therapeutique a base de flavono des destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
CNB998098353A CN1139384C (zh) | 1998-07-15 | 1999-07-13 | 用于与细胞毒性剂治疗肿瘤的基于类黄酮的治疗组合物 |
EA200100140A EA200100140A1 (ru) | 1998-07-15 | 1999-07-13 | Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами |
CA002337179A CA2337179A1 (fr) | 1998-07-15 | 1999-07-13 | Composition therapeutique a base de flavonoides, destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
BR9912816-0A BR9912816A (pt) | 1998-07-15 | 1999-07-13 | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos |
ZA200100239A ZA200100239B (en) | 1998-07-15 | 2001-01-09 | Therapeutic composition based on flavonoids for use in the treatment of tumors with cytotoxic agents. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9809058A FR2781153B1 (fr) | 1998-07-15 | 1998-07-15 | Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2781153A1 FR2781153A1 (fr) | 2000-01-21 |
FR2781153B1 true FR2781153B1 (fr) | 2001-08-03 |
Family
ID=9528648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9809058A Expired - Fee Related FR2781153B1 (fr) | 1998-07-15 | 1998-07-15 | Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1096930A1 (fr) |
JP (1) | JP2002520356A (fr) |
KR (1) | KR20020003349A (fr) |
CN (1) | CN1139384C (fr) |
AU (1) | AU4789099A (fr) |
BR (1) | BR9912816A (fr) |
CA (1) | CA2337179A1 (fr) |
EA (1) | EA200100140A1 (fr) |
FR (1) | FR2781153B1 (fr) |
IL (1) | IL140588A0 (fr) |
WO (1) | WO2000003706A1 (fr) |
ZA (1) | ZA200100239B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002069949A2 (fr) * | 2001-03-06 | 2002-09-12 | Prendergast Patrick T | Polytherapie pour la reduction de la toxicite d'agents chimiotherapeutiques |
EP1808172A3 (fr) * | 2002-03-06 | 2010-05-26 | Activephyto Technologies Limited | Compostions à base d'extraits botaniques et procédés d'utilisation |
DE60313754T2 (de) * | 2002-03-06 | 2008-01-24 | The Medical Research and Education Trust, San Diego | Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin |
US20030229136A1 (en) * | 2002-04-18 | 2003-12-11 | Nurulain Zaveri | Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
CN1679539A (zh) * | 2005-01-20 | 2005-10-12 | 吴一心 | 抗肿瘤的协同药物组合物 |
EP1856083A4 (fr) * | 2005-03-11 | 2009-05-27 | Univ Michigan | Inhibiteurs de chromen-4-one des elements anti-apoptotiques de la famille bcl-2 et utilisations |
GB0808974D0 (en) * | 2008-05-16 | 2008-06-25 | Veritron Ltd | Plant extract and its therapeutic use |
US9808439B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of tangeretin in cancer treatment |
US9808477B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of nobiletin in cancer treatment |
JP6775226B2 (ja) * | 2016-06-30 | 2020-10-28 | 国立大学法人広島大学 | 抗癌剤作用増強物質およびそれを備えた抗癌剤キット |
CN106562954A (zh) * | 2016-11-11 | 2017-04-19 | 黄冈师范学院 | (去甲基)多甲氧基黄酮联合紫杉醇类药物在制备治疗非小细胞肺癌的药物上的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0617304B2 (ja) * | 1982-09-09 | 1994-03-09 | 理化学研究所 | 制癌剤 |
JPS5959627A (ja) * | 1982-09-27 | 1984-04-05 | Tatsuo Miyoshi | 制癌剤 |
JPS60199817A (ja) * | 1984-03-23 | 1985-10-09 | Rikagaku Kenkyusho | 制癌剤 |
JPS632925A (ja) * | 1986-06-23 | 1988-01-07 | Nippon Kayaku Co Ltd | Cキナ−ゼ阻害剤および抗腫瘍剤 |
FR2633182B1 (fr) * | 1988-06-23 | 1993-07-23 | Beljanski Mirko | Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention |
JPH04103529A (ja) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | 制癌剤 |
JPH04103532A (ja) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | 制癌剤 |
JP2514500B2 (ja) * | 1991-09-14 | 1996-07-10 | 呉羽化学工業株式会社 | 多剤耐性抑制剤及び発現阻害剤 |
AU4272293A (en) * | 1992-05-11 | 1993-12-13 | Tsumura & Co. | Apoptosis inducer |
WO1996031206A2 (fr) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones et coumarines utilisees en tant qu'agents dans le traitement de l'atherosclerose |
DE29719198U1 (de) * | 1997-10-29 | 1998-04-23 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke | Flavono/Flavonoid-Zubereitung |
-
1998
- 1998-07-15 FR FR9809058A patent/FR2781153B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-13 KR KR1020017000478A patent/KR20020003349A/ko not_active Application Discontinuation
- 1999-07-13 EA EA200100140A patent/EA200100140A1/ru unknown
- 1999-07-13 JP JP2000559841A patent/JP2002520356A/ja active Pending
- 1999-07-13 BR BR9912816-0A patent/BR9912816A/pt not_active IP Right Cessation
- 1999-07-13 CA CA002337179A patent/CA2337179A1/fr not_active Abandoned
- 1999-07-13 CN CNB998098353A patent/CN1139384C/zh not_active Expired - Fee Related
- 1999-07-13 AU AU47890/99A patent/AU4789099A/en not_active Abandoned
- 1999-07-13 WO PCT/FR1999/001714 patent/WO2000003706A1/fr not_active Application Discontinuation
- 1999-07-13 EP EP99931342A patent/EP1096930A1/fr not_active Withdrawn
- 1999-07-13 IL IL14058899A patent/IL140588A0/xx unknown
-
2001
- 2001-01-09 ZA ZA200100239A patent/ZA200100239B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200100140A1 (ru) | 2001-06-25 |
CN1139384C (zh) | 2004-02-25 |
FR2781153A1 (fr) | 2000-01-21 |
EP1096930A1 (fr) | 2001-05-09 |
JP2002520356A (ja) | 2002-07-09 |
KR20020003349A (ko) | 2002-01-12 |
BR9912816A (pt) | 2001-05-08 |
CN1313765A (zh) | 2001-09-19 |
IL140588A0 (en) | 2002-02-10 |
WO2000003706A1 (fr) | 2000-01-27 |
ZA200100239B (en) | 2002-01-09 |
AU4789099A (en) | 2000-02-07 |
CA2337179A1 (fr) | 2000-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
EE200100618A (et) | Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks | |
BR9502797A (pt) | Complexos de análogo de insulina-protamina suas formulações farmaceuticas parenterais processos para preparação dos ditos análogos e das formulações farmacêuticas e cristais de insulina-protamina | |
DE69911221D1 (de) | Methode und gerät zur darreichung von therapeutischen mitteln in verbindung mit dem plazieren von radioaktiven körnern | |
IL112969A0 (en) | Pharmaceutical composition comprising t-cell actiVator for the treatment of cancer | |
HU0103558D0 (en) | Pharmaceutical composition for the treatment of stroke and traumatic brain insury | |
ZA899176B (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment | |
IL130784A0 (en) | Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same | |
IT1302365B1 (it) | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali | |
FR2781153B1 (fr) | Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques | |
HUP9904027A3 (en) | Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases | |
FR2781154B1 (fr) | Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques | |
FR2760639B1 (fr) | Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable | |
DE69939075D1 (de) | Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten | |
HK1032534A1 (en) | L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof | |
AU7793791A (en) | Pharmaceutical composition for use in treating pain | |
AU5587800A (en) | S-(+)-desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions | |
FR2751544B1 (fr) | Composition therapeutique pour le traitement des verrues vulgaires | |
DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
EE200200348A (et) | Ravimkoostis kasutamiseks valu ravis | |
TR199501530A1 (tr) | Osteoporoz tedavisinde terapötik döngüde kullanim icin kit. | |
HUP0105203A3 (en) | S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use | |
ID28817A (id) | Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri | |
EP0384302A3 (fr) | Usage d'ubenimex dans la fabrication d'un médicament pour le traitement du syndrome myélodysplastique | |
IL121680A0 (en) | Therapeutic substance for use in the treatment of and in the preparation of pharmaceutical compositions for the treatment of immuno-allergical diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |